A PPARα promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes.
Activation of peroxisome proliferator-activated receptor alpha (PPARα) occurs in animal models of diabetes (DM) and is implicated in pathological responses to myocardial ischemia. Using bioinformatics, we identified a single nucleotide polymorphism (SNP) in the PPARα gene promoter (PPARA -54,642 G&g...
Main Authors: | Sharon Cresci, Janice M Huss, Amber L Beitelshees, Philip G Jones, Matt R Minton, Gerald W Dorn, Daniel P Kelly, John A Spertus, Howard L McLeod |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-09-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2933242?pdf=render |
Similar Items
-
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
by: Sharon Cresci
Published: (2008-01-01) -
Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation
by: Anne Bugge, et al.
Published: (2010-01-01) -
microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription.
by: Priyatansh Gurha, et al.
Published: (2013-01-01) -
The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARγ-dependent and PPARγ-independent mechanisms
by: Jessica R. Miller, et al.
Published: (2008-03-01) -
Isolation and characterization of ischemia-derived astrocytes (IDA) with ability to transactivate quiescent astrocytes
by: Alejandro eVillarreal, et al.
Published: (2016-06-01)